Clinical Trials Browser

Phase 2 × Barrett Esophagus × 90 days × Clear all

NCT04939051 2026-03-18

Obeticholic Acid for Prevention in Barrett's Esophagus

Phase 2 Recruiting

Gastrointestinal

Adenocarcinoma Of Esophagus, Barrett Esophagus

NCT06732388 2026-03-18

Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus

Phase 2 Not yet recruiting

Gastrointestinal

Adenocarcinoma Of Esophagus, Barrett Esophagus